Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8264.71
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 09-Feb-2026
NAV [Rs.]
: 153.9213
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 3.57 | -1.43 | -1.46 | 0.55 | 2 | 23.08 | 15.32 | 17.76 |
| Category Avg | 1.23 | -5.24 | -5.13 | -3.06 | -2.39 | 22.43 | 14.51 | 12.1 |
| Category Best | 2.35 | -3.48 | -2.69 | -0.26 | 3.11 | 27.77 | 17.35 | 26.36 |
| Category Worst | -1.46 | -8.44 | -9.48 | -7.77 | -9.71 | 17.38 | 10.7 | -8.1 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
03-Feb-20261200
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
Orchid Pharma4,57,561
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.67 | 6256349 | 998.07 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.88 | 2883991 | 620.86 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.54 | 850754 | 514.79 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.06 | 3916074 | 477.01 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.88 | 3495054 | 462.74 |
| Equity | Apollo Hospitals | Healthcare Services | 5.73 | 648795 | 451.59 |
| Equity | Medplus Health | Retailing | 3.68 | 3627277 | 289.80 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.51 | 2886684 | 276.74 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.39 | 959323 | 266.87 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.78 | 913226 | 219.32 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.71 | 2555745 | 213.44 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.61 | 1702630 | 205.62 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.60 | 74187 | 204.49 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.55 | 1364742 | 200.72 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.45 | 907154 | 192.67 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.37 | 999649 | 186.88 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.34 | 4392120 | 184.46 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.33 | 323678 | 183.76 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.18 | 1218224 | 171.70 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.07 | 923911 | 163.33 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.88 | 800549 | 147.82 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.84 | 318249 | 145.23 |
| Equity | Max Healthcare | Healthcare Services | 1.51 | 1241340 | 118.77 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.39 | 746337 | 109.24 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.32 | 3896349 | 103.62 |
| Equity | Fortis Health. | Healthcare Services | 1.19 | 1103889 | 93.99 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.17 | 230272 | 92.51 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.15 | 213659 | 90.73 |
| Equity | Syngene Intl. | Healthcare Services | 1.13 | 1883372 | 89.16 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.03 | 2219374 | 81.40 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.85 | 1515264 | 66.60 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.81 | 1058503 | 63.43 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.68 | 62568 | 53.49 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.51 | 1834924 | 39.91 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.17 | 111738 | 13.13 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,11,597.56
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
